These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35575310)

  • 1. Development and validation of the patient-reported "Facial Function Scale" for facioscapulohumeral muscular dystrophy.
    Mul K; Wijayanto F; Loonen TGJ; Groot P; Vincenten SCC; Knuijt S; Groothuis JT; Maal TJJ; Heskes T; Voermans NC; Engelen BGMV
    Disabil Rehabil; 2023 May; 45(9):1530-1535. PubMed ID: 35575310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The facioscapulohumeral muscular dystrophy Rasch-built overall disability scale (FSHD-RODS).
    Mul K; Hamadeh T; Horlings CGC; Tawil R; Statland JM; Sacconi S; Corbett AJ; Voermans NC; Faber CG; van Engelen BGM; Merkies ISJ
    Eur J Neurol; 2021 Jul; 28(7):2339-2348. PubMed ID: 33838063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facing facial weakness: psychosocial outcomes of facial weakness and reduced facial function in facioscapulohumeral muscular dystrophy.
    van de Geest-Buit WA; Rasing NB; Mul K; Deenen JCW; Vincenten SCC; Siemann I; Lanser A; Groothuis JT; van Engelen BG; Custers JAE; Voermans NC
    Disabil Rehabil; 2023 Jul; 45(15):2507-2516. PubMed ID: 35815498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The facioscapulohumeral muscular dystrophy - health index: Italian validation of a disease-specific measure of symptomatic burden.
    Carraro E; Greco LC; Lizio A; Beretta M; Pozzi S; Casiraghi J; Becchiati S; Beshiri F; Frisoni MC; Iossa F; Heatwole C; Sansone V
    Disabil Rehabil; 2024 May; 46(10):2130-2137. PubMed ID: 37194629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Facioscapulohumeral Muscular Dystrophy-Health Index: Development and evaluation of a disease-specific outcome measure.
    Varma A; Weinstein J; Seabury J; Rosero S; Engebrecht C; Wagner E; Zizzi C; Luebbe EA; Dilek N; McDermott MP; Kissel J; Sansone V; Heatwole C
    Muscle Nerve; 2023 Oct; 68(4):422-431. PubMed ID: 37610084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Approaches for Altered Facial Expression: A Systematic Review in Facioscapulohumeral Muscular Dystrophy and Other Neurological Diseases.
    Rasing NB; van de Geest-Buit WA; Chan OYA; Mul K; Lanser A; van Engelen BGM; Erasmus CE; Fischer AH; Ingels KJAO; Post B; Siemann I; Groothuis JT; Voermans NC
    J Neuromuscul Dis; 2024; 11(3):535-565. PubMed ID: 38517799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the face in facioscapulohumeral muscular dystrophy.
    Loonen TGJ; Horlings CGC; Vincenten SCC; Beurskens CHG; Knuijt S; Padberg GWAM; Statland JM; Voermans NC; Maal TJJ; van Engelen BGM; Mul K
    J Neurol; 2021 Apr; 268(4):1342-1350. PubMed ID: 33113021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experiences of patients with facioscapulohumeral dystrophy with facial weakness: a qualitative study.
    Sezer S; Cup EHC; Roets-Merken LM; Lanser A; Siemann I; Weikamp JG; Mul K; van Engelen BG; Satink T; Voermans NC
    Disabil Rehabil; 2022 Nov; 44(22):6775-6782. PubMed ID: 34529524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facioscapulohumeral muscular dystrophy Health Index: Japanese translation and validation study.
    Fujino H; Takahashi MP; Nakamura H; Heatwole CR; Takada H; Kuru S; Ogata K; Enomoto K; Hayashi Y; Imura O; Matsumura T
    Disabil Rehabil; 2024 Mar; ():1-10. PubMed ID: 38555736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rasch analysis to evaluate the motor function measure for patients with facioscapulohumeral muscular dystrophy.
    Mul K; Horlings CGC; Faber CG; van Engelen BGM; Merkies ISJ
    Int J Rehabil Res; 2021 Mar; 44(1):38-44. PubMed ID: 33165002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facioscapulohumeral muscular dystrophy functional composite outcome measure.
    Eichinger K; Heatwole C; Iyadurai S; King W; Baker L; Heininger S; Bartlett A; Dilek N; Martens WB; Mcdermott M; Kissel JT; Tawil R; Statland JM
    Muscle Nerve; 2018 Jan; ():. PubMed ID: 29381807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pediatric case report and literature review of facioscapulohumeral muscular dystrophy type1.
    Xiao T; Yang H; Gan S; Wu L
    Medicine (Baltimore); 2021 Nov; 100(47):e27907. PubMed ID: 34964760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facioscapulohumeral Muscular Dystrophy European Patient Survey: Assessing Patient Reported Disease Burden and Preferences in Clinical Trial Participation.
    McNiff MM; Hawkins S; Haase B; Bullivant J; McIver T; Mitelman O; Emery N; Tasca G; Voermans N; Diaz-Manera J
    J Neuromuscul Dis; 2024; 11(2):459-472. PubMed ID: 38277300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability and validity of the FSHD-composite outcome measure in childhood facioscapulohumeral dystrophy.
    de Valle K; Dobson F; Woodcock I; Carroll K; Ryan MM; Heatwole C; Eichinger K; McGinley JL
    Neuromuscul Disord; 2021 Aug; 31(8):706-715. PubMed ID: 34210539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convergence of patient- and physician-reported outcomes in the French National Registry of Facioscapulohumeral Dystrophy.
    Sanson B; Stalens C; Guien C; Villa L; Eng C; Rabarimeriarijaona S; Bernard R; Cintas P; Solé G; Tiffreau V; Echaniz-Laguna A; Magot A; Juntas Morales R; Boyer FC; Nadaj-Pakleza A; Jacquin-Piques A; Béroud C; Sacconi S;
    Orphanet J Rare Dis; 2022 Mar; 17(1):96. PubMed ID: 35236385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Face to Face: deciphering facial involvement in inclusion body myositis.
    Fortanier E; Delmont E; Kouton L; Corazza G; Grapperon AM; Verschueren A; Attarian S; Salort-Campana E
    J Neurol; 2024 Jan; 271(1):410-418. PubMed ID: 37740740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The upper extremity functional index (UEFI): Italian validation in patients with Facioscapulohumeral muscular dystrophy.
    Lizio A; Greco L; Beretta M; Frisoni MC; Becchiati S; Casiraghi J; Sansone VA; Carraro E
    Disabil Rehabil; 2024 Jul; 46(15):3462-3468. PubMed ID: 37578105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score.
    Lamperti C; Fabbri G; Vercelli L; D'Amico R; Frusciante R; Bonifazi E; Fiorillo C; Borsato C; Cao M; Servida M; Greco F; Di Leo R; Volpi L; Manzoli C; Cudia P; Pastorello E; Ricciardi L; Siciliano G; Galluzzi G; Rodolico C; Santoro L; Tomelleri G; Angelini C; Ricci E; Palmucci L; Moggio M; Tupler R
    Muscle Nerve; 2010 Aug; 42(2):213-7. PubMed ID: 20544930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrical impedance myography in facioscapulohumeral muscular dystrophy.
    Statland JM; Heatwole C; Eichinger K; Dilek N; Martens WB; Tawil R
    Muscle Nerve; 2016 Oct; 54(4):696-701. PubMed ID: 26840230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large genotype-phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis.
    Ricci G; Mele F; Govi M; Ruggiero L; Sera F; Vercelli L; Bettio C; Santoro L; Mongini T; Villa L; Moggio M; Filosto M; Scarlato M; Previtali SC; Tripodi SM; Pegoraro E; Telese R; Di Muzio A; Rodolico C; Bucci E; Antonini G; D'Angelo MG; Berardinelli A; Maggi L; Piras R; Maioli MA; Siciliano G; Tomelleri G; Angelini C; Tupler R
    Sci Rep; 2020 Dec; 10(1):21648. PubMed ID: 33303865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.